MTOR and Cognitive impairment: Consistent with a specific role of mTOR in the cognitive impairment induced by 5-HT6 receptor activation, rapamycin did not block the deficit in social recognition induced by the muscarinic receptor antagonist scopolamine (1.25 mg/kg s.c., Supporting Information Fig S9).